Evaluation of GALAD Score in Diagnosis and Follow-up of Hepatocellular Carcinoma after Local Ablative Therapy

BACKGROUND AND AIMS: Strategies for detection of early hepatocellular carcinoma (HCC) are still limited. The GALAD score is a serum biomarker-based model designed to predict the probability of having HCC. We aimed to assess the ability of GALAD score to diagnose early HCC and its validity to follow...

Descripción completa

Detalles Bibliográficos
Autores principales: Eletreby, Rasha, Elsharkawy, Marwa, Taha, Alaa Awad, Hassany, Mohamed, Abdelazeem, Amr, El-Kassas, Mohamed, Soliman, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817041/
https://www.ncbi.nlm.nih.gov/pubmed/36643039
http://dx.doi.org/10.14218/JCTH.2022.00013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817041/
https://www.ncbi.nlm.nih.gov/pubmed/36643039
http://dx.doi.org/10.14218/JCTH.2022.00013

Ejemplares similares